The Andro/Etio ratio compares the levels of two key androgen metabolites, androsterone (Andro) and etiocholanolone (Etio), which are produced from DHEA and androstenedione through the 5α- and 5β-reductase pathways, respectively. This ratio provides insights into the balance of androgen metabolism and the activity of these two reductase enzymes.
-
A higher Andro/Etio ratio reflects increased 5α-reductase activity, favoring the conversion of androgens into androsterone. Elevated 5α-reductase activity is often associated with conditions like polycystic ovary syndrome (PCOS), androgen dominance, or metabolic syndrome.
-
A lower Andro/Etio ratio suggests increased 5β-reductase activity, favoring the production of etiocholanolone. This may occur in conditions with altered androgen metabolism or impaired 5α-reductase function.
Evaluating the Andro/Etio ratio helps clinicians assess the enzymatic balance of androgen metabolism, identify potential hormonal imbalances, and tailor interventions to optimize androgen-related health outcomes.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.